Accession Number: | 0001415889-21-002924 |
Date: | 2021-06-09 |
Issuer: | OLEMA PHARMACEUTICALS, INC. (OLMA) |
Original Submission Date: |
LARSON YI
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO, CA 94107
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 27.66 | 2021-06-09 | deemed execution date | A | 21,520 (a) | 2031-06-08 | common stock 21,520 | $27.66 | 21,520 | direct |
ID | footnote |
---|---|
f1 | the shares subject to the option vest in a series of 12 successive equal monthly installments measured from june 9, 2021, subject to the reporting person's continuous service through each applicable vesting date. such shares vest in full on the date of the issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the reporting person's continuous service through such vesting date. |